Nuzenio

First Word

First Word news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 19 latest news signals 5 publisher sources 100/100 entity strength

Latest news

MoonLake touts Phase III PsA data, but investors may have wanted more - FirstWord PharmaFirstWord Pharma · Mon, 10 Aug 2026 18:17:18 GMTSilence posts mid-stage polycythemia vera win, preps for Phase III - FirstWord PharmaFirstWord Pharma · Mon, 10 Aug 2026 18:02:18 GMTVertex's would-be rival Sionna scraps cystic fibrosis drug add-on after trial flop - FirstWord PharmaFirstWord Pharma · Mon, 10 Aug 2026 16:12:18 GMTSobi, Innate sign $580M pact to propel lymphoma drug through Phase III - FirstWord PharmaFirstWord Pharma · Mon, 10 Aug 2026 15:22:30 GMTSpotlight On: Takeda breaks new ground with narcolepsy approval as Alkermes and Eli Lilly wait in slipstream - FirstWord PharmaFirstWord Pharma · Mon, 10 Aug 2026 15:18:08 GMTPhysician Views Preview: Orzeyful arrives — Will Takeda's drug redefine narcolepsy treatment? - FirstWord PharmaFirstWord Pharma · Mon, 10 Aug 2026 15:18:06 GMTTenax sees 'clear path forward' for heart failure drug despite Phase III miss - FirstWord PharmaFirstWord Pharma · Mon, 10 Aug 2026 13:48:18 GMTJazz to buy Actio for up to $1.32B, gaining epilepsy asset - FirstWord PharmaFirstWord Pharma · Mon, 10 Aug 2026 13:48:18 GMT

Timeline

Mon, 10 Aug 2026 18:17:18 GMTMoonLake touts Phase III PsA data, but investors may have wanted more - FirstWord Pharma
Mon, 10 Aug 2026 18:02:18 GMTSilence posts mid-stage polycythemia vera win, preps for Phase III - FirstWord Pharma
Mon, 10 Aug 2026 16:12:18 GMTVertex's would-be rival Sionna scraps cystic fibrosis drug add-on after trial flop - FirstWord Pharma
Mon, 10 Aug 2026 15:22:30 GMTSobi, Innate sign $580M pact to propel lymphoma drug through Phase III - FirstWord Pharma
Mon, 10 Aug 2026 15:18:08 GMTSpotlight On: Takeda breaks new ground with narcolepsy approval as Alkermes and Eli Lilly wait in slipstream - FirstWord Pharma
Mon, 10 Aug 2026 15:18:06 GMTPhysician Views Preview: Orzeyful arrives — Will Takeda's drug redefine narcolepsy treatment? - FirstWord Pharma

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for First Word.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.